This release contains "forward-looking" statements regarding future
results and events. For this purpose, any statements contained herein that
are not statements of historical fact may be deemed forward-looking
statements. Without limiting the foregoing, the words "believes,"
"anticipates," "plans," "expects," "intends," "appears," "estimates,"
"projects," "targets," and similar expressions are also intended to
identify forward-looking statements. The forward-looking statements in this
release involve a number of risks and uncertainties. The Company's actual
future results may differ significantly from the results discussed in the
forward-looking statements contained in this release. Important factors
that might cause such a difference include, but are not limited to, risks
associated with: actual operating performance; actual expense savings and
other operating improvements resulting from recent restructurings; the
loss, modification, or delay of contracts which would, among other things,
adversely impact the Company's recognition of revenue included in backlog;
the Company's dependence on certain industries and clients; the Company's
ability to win new business, manage growth and costs, and attract and
retain employees; the Company's ability to complete additional acquisitions
and to integrate newly acquired businesses or enter into new lines of
business, including APEX; the impact on the Company's business of
government regulation of the drug, medical device and biotechnology
|SOURCE PAREXEL International Corporation|
Copyright©2007 PR Newswire.
All rights reserved